MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
吸食大麻与肺癌和其他癌症的风险
基本信息
- 批准号:6174697
- 负责人:
- 金额:$ 48.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:adult human (21+) cancer risk clinical chemistry clinical research data management depression drug related neoplasm /cancer esophagus neoplasm gender difference histology human subject interview larynx neoplasms longitudinal human study lung neoplasms molecular oncology neoplasm /cancer epidemiology oral pharyngeal neoplasm smoking socioeconomics statistics /biometry substance abuse epidemiology tobacco
项目摘要
Marijuana is the most widely used illegal drug in the United States.
Although marijuana use had decreased substantially since the late 1970s,
it has risen dramatically since 1992 among teenagers and young adults.
One possible factor contributing to this upsurge is the widespread
belief that there are no chronic adverse health effects of regular
marijuana use. In November 1996, California voters passed Proposition
215, which would legalize the use of marijuana for medicinal purposes.
Despite scientific debate about the benefits of marijuana treatment, the
public's perception seems to be that the potential benefits outweigh the
risks. Nevertheless, several lines of evidence from biochemical,
cellular, tissue and animal studies provide a biologically plausible
basis for the hypothesis that marijuana is a risk factor for
respiratory-tract cancers. Thus far, however, there is no epidemiologic
evidence for this association, primarily because of the long
induction/latency of human carcinomas and the infrequent use of
marijuana in the general U.S. population before the late '60s. The major
objective of the proposed 5-year project is to estimate the effects of
marijuana use on the risk of lung cancer and upper-aerodigestive-tract
(UAT) cancers among residents of Los Angeles County, ages 18-57.
Secondary objectives are to assess the interaction effects of marijuana
and tobacco use, to estimate the effects of other factors for which the
epidemiologic evidence is inconsistent or sparse, and to initiate a
molecular study by obtaining tumor specimens for cases and buccal cells
from cases and controls.
The proposed design is a population-based case-control study involving
600 lung-cancer cases, 600 UAT-cancer cases (395 oral cavity and
pharynx, 85 esophagus, and 120 larynx), and 1,200 controls.
Histologically confirmed cases will be identified by the rapid
ascertainment system of the USC Cancer Surveillance Program, a
population-based SEER registry for Los Angeles County. Controls will be
selected according to a prespecified algorithm from the neighborhoods
of cases; one control will be matched to each case on age, sex,
race/ethnicity, and neighborhood. The major source of data will be
personal interviews conducted with all subjects in their homes.
Information will be collected on a variety of factors: detailed history
of marijuana, tobacco and alcohol use; occupational and environmental
exposures (e.g., passive smoking); clinical factors (e.g., depression
and family history of cancer); diet and other behaviors (e.g., fruits,
vegetables, fats, and supplements); and sociodemographic factors (e.g.,
SES).
大麻是美国使用最广泛的非法药物。
尽管自20世纪70年代末以来大麻的使用大幅减少,
自1992年以来,青少年和年轻人中的艾滋病发病率急剧上升。
导致这一激增的一个可能因素是,
相信有没有慢性不良健康影响的定期
吸食大麻 1996年11月,加州选民通过了
215,这将合法化大麻用于药用目的。
尽管关于大麻治疗的益处存在科学争论,
公众的看法似乎是,潜在的好处超过了
风险 尽管如此,从生物化学,
细胞、组织和动物研究提供了一种生物学上合理的
假设大麻是一个危险因素的基础,
尿道癌 然而,到目前为止,还没有流行病学
这种关联的证据,主要是因为
人类癌症的诱导/潜伏期以及
在60年代末之前,大麻在美国普通人群中的使用率。主要
拟议的5年项目的目标是估计
大麻使用对肺癌和上呼吸消化道的风险
(UAT)洛杉矶县18-57岁居民中的癌症。
次要目的是评估大麻的相互作用效应
和烟草使用,以估计其他因素的影响,
流行病学证据是不一致或稀疏的,并启动一个
通过获得病例的肿瘤标本和颊细胞进行分子研究
从病例和对照组中。
本研究是一项基于人群的病例对照研究,
肺癌600例,UAT癌600例(口腔癌395例,
咽,85食管,和120喉)和1,200对照。
组织学确诊病例将通过快速
南加州大学癌症监测计划的确定系统,
洛杉矶县基于人口的SEER登记。控件将被
根据预先指定的算法从邻域中选择
的病例;一个对照组将与每个病例的年龄、性别
种族/民族和邻里。 数据的主要来源是
在所有受试者家中进行个人访谈。
将收集各种因素的信息:
大麻,烟草和酒精的使用;职业和环境
暴露(例如,被动吸烟);临床因素(例如,抑郁
和癌症家族史);饮食和其他行为(例如,水果,
蔬菜、脂肪和补充剂);和社会人口因素(例如,
SES)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAL M MORGENSTERN其他文献
HAL M MORGENSTERN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAL M MORGENSTERN', 18)}}的其他基金
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
吸食大麻与肺癌和其他癌症的风险
- 批准号:
6515599 - 财政年份:1999
- 资助金额:
$ 48.58万 - 项目类别:
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
吸食大麻与肺癌和其他癌症的风险
- 批准号:
2761718 - 财政年份:1999
- 资助金额:
$ 48.58万 - 项目类别:
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
吸食大麻与肺癌和其他癌症的风险
- 批准号:
6378717 - 财政年份:1999
- 资助金额:
$ 48.58万 - 项目类别:
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
吸食大麻与肺癌和其他癌症的风险
- 批准号:
6804317 - 财政年份:1999
- 资助金额:
$ 48.58万 - 项目类别:
CHIROPRACTIC VERSUS MEDICAL CARE FOR LOW-BACK PAIN
腰痛的脊椎按摩治疗与医疗护理
- 批准号:
2236232 - 财政年份:1995
- 资助金额:
$ 48.58万 - 项目类别:
CHIROPRACTIC VERSUS MEDICAL CARE FOR LOW-BACK PAIN
腰痛的脊椎按摩治疗与医疗护理
- 批准号:
2702851 - 财政年份:1995
- 资助金额:
$ 48.58万 - 项目类别:
CHIROPRACTIC VERSUS MEDICAL CARE FOR LOW-BACK PAIN
腰痛的脊椎按摩治疗与医疗护理
- 批准号:
2910700 - 财政年份:1995
- 资助金额:
$ 48.58万 - 项目类别:
CHIROPRACTIC VERSUS MEDICAL CARE FOR LOW BACK PAIN
腰痛的脊椎按摩治疗与医疗护理
- 批准号:
2236231 - 财政年份:1995
- 资助金额:
$ 48.58万 - 项目类别:
CHIROPRACTIC VERSUS MEDICAL CARE FOR LOW-BACK PAIN
腰痛的脊椎按摩治疗与医疗护理
- 批准号:
2415710 - 财政年份:1995
- 资助金额:
$ 48.58万 - 项目类别:
相似海外基金
Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
- 批准号:
494953 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Operating Grants
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
- 批准号:
10805177 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
- 批准号:
10912190 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
- 批准号:
478999 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
- 批准号:
495159 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
- 批准号:
10650054 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
- 批准号:
10733566 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
- 批准号:
10586626 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
- 批准号:
10582944 - 财政年份:2023
- 资助金额:
$ 48.58万 - 项目类别:














{{item.name}}会员




